Cancer-Associated STAT3 Mutations Maintain ES Cell Self-Renewal Through Phosphorylation-Independent Mechanisms

Area of Science:

• Stem cell biology
• Molecular genetics
• Human disease mechanisms

Background:

• Signal transducer and activator of transcription 3 (STAT3) is crucial for embryonic stem (ES) cell self-renewal.
• Aberrant STAT3 activity and mutations are implicated in various human diseases.
• Understanding STAT3's role in stem cells is vital for developmental and pathological insights.

Purpose of the Study:

• To investigate the impact of specific disease-associated STAT3 mutations (Y640F and G656insF) on ES cell properties.
• To determine the mechanism by which these STAT3 mutations affect ES cell self-renewal.
• To explore the independence of these mutations from endogenous STAT3 signaling.

Main Methods:

• Utilized embryonic stem (ES) cells carrying disease-associated STAT3 mutations (Y640F, G656insF).
• Assessed ES cell self-renewal capacity in the absence of standard self-renewal factors (LIF, MEK/GSK3 inhibitors).
• Analyzed STAT3 transcriptional activity and phosphorylation status post-LIF stimulation.
• Employed STAT3 knockout ES cells to evaluate mutation function independently of endogenous STAT3.

Main Results:

• STAT3 mutations Y640F and G656insF sustained ES cell self-renewal without LIF or MEK/GSK3 inhibition.
• Mutated STAT3 exhibited enhanced transcriptional activity but unchanged phosphorylation levels after LIF stimulation.
• The effects of these STAT3 mutations were independent of endogenous STAT3, confirmed in STAT3 knockout ES cells.

Conclusions:

• Disease-associated STAT3 mutations can maintain stem cell self-renewal through novel, phosphorylation-independent pathways.
• These findings elucidate how specific STAT3 mutations influence stem cell behavior in both normal development and disease states.
• Highlights a potential mechanism for STAT3-driven pathologies originating from stem cell dysregulation.